| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $748 | -25.5% | -89.1% |
| Cost of Revenue | $732 | -27.2% | -99.8% |
| Gross Profit | $16 | +1700.0% | +100.0% |
| R&D Expense | $672K | -12.1% | +36.7% |
| SG&A Expense | $2.5M | -51.1% | -33.8% |
| Operating Income | -$3.1M | +49.0% | +33.2% |
| Pre-tax Income | -$24.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $163K | -49.6% | -50.4% |
| Accounts Receivable | $39K | -1.4% | -88.9% |
| Inventory | $7K | -13.7% | -92.6% |
| Current Assets | $420K | -3.0% | -79.9% |
| Total Assets | $11.8M | -63.9% | -60.5% |
| Current Liabilities | $20.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.4M | — | — |
| Investing Cash Flow | -$2.4M | — | — |
| Financing Cash Flow | $18.2M | — | — |
| -227.3% |
| -246.8% |
| Net Income | -$24.0M | -231.3% | -87.2% |
| EPS (Basic) | -$548.78 | — | -394.1% |
| EPS (Diluted) | -$548.78 | — | -394.1% |
| +0.4% |
| -15.2% |
| Total Liabilities | $20.7M | -0.2% | -18.6% |
| Stockholders' Equity | -$7.7M | -159.7% | -264.1% |